Quick Search


 

Result Summaries: cabotegravir

ViiV
Study ID
   Phase    Title Summary (Download)
116482 phase 2 A Phase IIb, dose ranging study of oral GSK1265744 in combination with nucleoside reverse transcriptase inhibitors for induction of human immunodeficiency virus -1 (HIV-1) virologic suppression followed by an evaluation of maintenance of virologic suppression when oral GSK1265744 is combined with oral rilpivirine in HIV-1 infected, antiretroviral therapy naive adult subjects (0 citation(s)) Click here to download result summary.
117010 Phase 1 Phase I, single-center, open label, fixed-sequence cross-over study to evaluate the effect of rifampin on the pharmacokinetics of oral cabotegravir in healthy subjects (0 citation(s)) Click here to download result summary.
200056 phase 2 A Phase IIb Study Evaluating a Long-Acting Intramuscular Regimen of GSK1265744 plus TMC278 For The Maintenance of Virologic Suppression Following an Induction of Virologic Suppression on an Oral regimen of GSK1265744 plus Abacavir/Lamivudine in HIV-1 Infected, Antiretroviral Therapy-Naive Adult Subjects (0 citation(s)) Click here to download result summary.
201120 phase 2 A Phase IIa Study to Evaluate the Safety, Tolerability and Acceptability of Long Acting Injections of the HIV Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR) (0 citation(s)) Click here to download result summary.
201479 Phase 1 A Phase I Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 in Subjects with Hepatic Impairment and Healthy Matched Control Subjects (0 citation(s)) Click here to download result summary.
201480 Phase 1 A Phase I, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 in Subjects with Severe Renal Impairment and Healthy Matched Control Subjects (0 citation(s)) Click here to download result summary.
205162 PGX7646: Evaluation of relationships between UGT1A1 and UGT1A9 genotypes and cabotegravir pharmacokinetics and tolerability (0 citation(s)) Click here to download result summary.
205696 Phase 1 A Phase I study evaluating the effect of a high fat meal on the pharmacokinetics of cabotegravir in healthy adult volunteers (0 citation(s)) Click here to download result summary.